Sage Therapeutics stock surges 70% on high hopes for depression drug

Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.